Home

Market Capitalization of Dr Reddys Laboratories Ltd

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Market Cap

₹ 107511.36 crore

Last updated on: Jan 21, 2025

Key Highlights

  • The Market Cap of Dr Reddys Laboratories Ltd is ₹ 107511 crore as of 21 Jan 25 .
  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1296 as of 22 Jan 15:30 .
  • The Dividend Payouts of Dr Reddys Laboratories Ltd changed from ₹ 20 on Jul 15, 2019 to ₹ 40 on Jul 16, 2024 . This represents a CAGR of 12.25% over 6 years.
Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Share Price

₹ 1296.3

7.85 (0.61%)

stock direction

Last updated on: Jan 22, 2025

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Jan 20251288.45
20 Jan 20251302.05
17 Jan 20251309.85
16 Jan 20251303.3
15 Jan 20251339.2
14 Jan 20251337.3
13 Jan 20251334.15
10 Jan 20251354.2
09 Jan 20251371.6
08 Jan 20251370.6

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Dr Reddys Laboratories Ltd

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Dr Reddys Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Dr Reddys Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Dr Reddys Laboratories Ltd

No data available

* All values are in

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories was incorporated in the year 1984 in Hyderabad.

Dr Reddys Laboratories Ltd News Hub

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707

Read more

21 Aug 2024

Dr Reddy's formulations manufacturing units receives EIR from USFDA

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m

Read more

12 Aug 2024

Dr Reddys allots 29,790 equity shares under ESOP

Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu

Read more

07 Aug 2024

Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA

The inspection has been classified as voluntary action indicated (VAI) and has been closed according

Read more

06 Sep 2024

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Dr Reddys Laboratories Ltd Market Cap

What is the market cap of Dr Reddys Laboratories Ltd?

As of January 22, 2025, Dr Reddys Laboratories Ltd has a market capitalization of ₹107511.36, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Dr Reddys Laboratories Ltd's market capitalization?

Dr Reddys Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Dr Reddys Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Dr Reddys Laboratories Ltd's market capitalization change?

Dr Reddys Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions